Friday's Top 10 Articles, Videos on TheStreet
NEW YORK (TheStreet) -- In case you missed them, here are the top 10 most popular articles and videos on TheStreet today. Sign up for free email delivery of our daily Top 10.
Biotech Stock Mailbag: Cyclacel Fallout, the Skinny on Vivus, Celldex's Crash
Adam Feuerstein
Biotech columnist Adam Feuerstein answers readers' questions about health-care companies. (Stocks include CYCC, VVUS, CLDX)
The Next Big Thing in Biotech: Discovery Labs
Gregg Greenberg
Senior columnist Adam Feuerstein explains why Discovery Labs is the next big thing in biotech.
The 5 Dumbest Things on Wall Street -- Silent Movie Version
Gregg Greenberg
The show must go on, even if the host loses his voice.
Shanthi Bharatwaj
New fees from Bank of America revives debate on whether banks can offset revenue losses by charging customers. 9 Gold, Oil Stocks That Rise on Bad News (Update 1)
Frank Byrt
These companies thrive on political and economic uncertainty -- two things that are certain for the rest of the year. Investors May Cry For Yelp After IPO (Update 1)
Chris Ciaccia
Reviews site Yelp is going public today. Investors may want to stay away for a variety of reasons. 7 Ex-Dividend Stocks With Buy Ratings
Alexandra Zendrian
These stocks, which go ex-dividend Monday, are rated buy at TheStreet Ratings. Stocks Waver as Investors Eye Europe
Chao Deng
Stocks waver as European markets weaken and investors watch for developments in Greece's bailout. Bank Rate Bomb Will Destroy the Smallest and Weakest
Philip van Doorn
The nation's community banks had better be prepared for the possibility of a quick spike in rates of up to 400 basis points within the next few years. 7 Dividend Stocks That Want to Pay You More Cash
Jonas Elmerraji
These companies recently increased their dividend payouts to shareholders.
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
